Baishan Jiang

12PUBLICATIONS
82CO-AUTHORS
Biologically active moleculesMolecular targetsGlycoconjugatesInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 28, 2026
Selective and Potent First-in-Class CRBN-Dependent Molecular Glue Degraders of WW Domain-Binding Protein 4.

|Jan 08, 2026
CDK10 suppresses nucleic acid sensors-mediated antitumor immunity.

Gaoshan Xu, Fusheng Guo, Chuan He

|Apr 23, 2025
Acute BRCAness induction and AR pathway blockage through CDK12/7/9 degradation enhances PARP inhibitor sensitivity in prostate cancer.

Fu Gui, Baishan Jiang, Jie Jiang

|Feb 10, 2025
Selective and Potent Molecular Glue Degraders for NIMA-Related Kinase 7.

Lu Chen, Lu Huang, Wuqiang Wen

|Mar 17, 2024
Therapeutic targeting nudix hydrolase 1 creates a MYC-driven metabolic vulnerability.

Minhui Ye, Yingzhe Fang, Lu Chen

|Aug 25, 2023
PROTAC-mediated CDK degradation differentially impacts cancer cell cycles due to heterogeneity in kinase dependencies.

Vishnu Kumarasamy, Zhe Gao, Bosheng Zhao

Pageof 2

Frequent Collaborators

5 joint publications

Nathanael S Gray

2 joint publications

Anne Fassl

2 joint publications

Guoliang Qing

2 joint publications

Eric S Fischer